The AI-PROGNOSIS consortium held its 7th Plenary Meeting on 4–5 June 2026 in Athens, Greece, hosted by project partner Netcompany. Partners reviewed the project's latest progress and aligned on priorities for the coming months.

Over two days, the consortium discussed updates across all active areas of the project – from data harmonisation and platform development to clinical study recruitment, digital biomarker research, and dissemination and communication activities. Progress on exploitation and regulatory planning was also presented.

An External Expert Advisory Board (EEAB) session was held, where members reviewed key research outcomes and provided scientific and strategic feedback.

The plenary concluded with a summary of agreed actions and priorities. Partners will focus on advancing clinical study recruitment, continuing development of the AI-PROGNOSIS platform, progressing scientific work on digital biomarkers and predictive models, and delivering the next planned milestones and deliverables.